Cargando…
Management of atrial fibrillation: focus on the role of dronedarone
BACKGROUND: Dronedarone is an amiodarone derivative that was approved in the US in July 2009 to reduce the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF), who are in sinus rhythm (SR), or who will be cardioverted. OBJECTIVE: This article rev...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753968/ https://www.ncbi.nlm.nih.gov/pubmed/27147853 http://dx.doi.org/10.2147/OAEM.S16679 |